Cargando…
Harnessing the Helminth Secretome for Therapeutic Immunomodulators
Helminths are the largest and most complex pathogens to invade and live within the human body. Since they are not able to outpace the immune system by rapid antigen variation or faster cell division or retreat into protective niches not accessible to immune effector mechanisms, their long-term survi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123613/ https://www.ncbi.nlm.nih.gov/pubmed/25133189 http://dx.doi.org/10.1155/2014/964350 |
_version_ | 1782329520400891904 |
---|---|
author | Ditgen, Dana Anandarajah, Emmanuela M. Meissner, Kamila A. Brattig, Norbert Wrenger, Carsten Liebau, Eva |
author_facet | Ditgen, Dana Anandarajah, Emmanuela M. Meissner, Kamila A. Brattig, Norbert Wrenger, Carsten Liebau, Eva |
author_sort | Ditgen, Dana |
collection | PubMed |
description | Helminths are the largest and most complex pathogens to invade and live within the human body. Since they are not able to outpace the immune system by rapid antigen variation or faster cell division or retreat into protective niches not accessible to immune effector mechanisms, their long-term survival depends on influencing and regulating the immune responses away from the mode of action most damaging to them. Immunologists have focused on the excretory and secretory products that are released by the helminths, since they can change the host environment by modulating the immune system. Here we give a brief overview of the helminth-associated immune response and the currently available helminth secretome data. We introduce some major secretome-derived immunomodulatory molecules and describe their potential mode of action. Finally, the applicability of helminth-derived therapeutic proteins in the treatment of allergic and autoimmune inflammatory disease is discussed. |
format | Online Article Text |
id | pubmed-4123613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-41236132014-08-17 Harnessing the Helminth Secretome for Therapeutic Immunomodulators Ditgen, Dana Anandarajah, Emmanuela M. Meissner, Kamila A. Brattig, Norbert Wrenger, Carsten Liebau, Eva Biomed Res Int Review Article Helminths are the largest and most complex pathogens to invade and live within the human body. Since they are not able to outpace the immune system by rapid antigen variation or faster cell division or retreat into protective niches not accessible to immune effector mechanisms, their long-term survival depends on influencing and regulating the immune responses away from the mode of action most damaging to them. Immunologists have focused on the excretory and secretory products that are released by the helminths, since they can change the host environment by modulating the immune system. Here we give a brief overview of the helminth-associated immune response and the currently available helminth secretome data. We introduce some major secretome-derived immunomodulatory molecules and describe their potential mode of action. Finally, the applicability of helminth-derived therapeutic proteins in the treatment of allergic and autoimmune inflammatory disease is discussed. Hindawi Publishing Corporation 2014 2014-07-15 /pmc/articles/PMC4123613/ /pubmed/25133189 http://dx.doi.org/10.1155/2014/964350 Text en Copyright © 2014 Dana Ditgen et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Ditgen, Dana Anandarajah, Emmanuela M. Meissner, Kamila A. Brattig, Norbert Wrenger, Carsten Liebau, Eva Harnessing the Helminth Secretome for Therapeutic Immunomodulators |
title | Harnessing the Helminth Secretome for Therapeutic Immunomodulators |
title_full | Harnessing the Helminth Secretome for Therapeutic Immunomodulators |
title_fullStr | Harnessing the Helminth Secretome for Therapeutic Immunomodulators |
title_full_unstemmed | Harnessing the Helminth Secretome for Therapeutic Immunomodulators |
title_short | Harnessing the Helminth Secretome for Therapeutic Immunomodulators |
title_sort | harnessing the helminth secretome for therapeutic immunomodulators |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123613/ https://www.ncbi.nlm.nih.gov/pubmed/25133189 http://dx.doi.org/10.1155/2014/964350 |
work_keys_str_mv | AT ditgendana harnessingthehelminthsecretomefortherapeuticimmunomodulators AT anandarajahemmanuelam harnessingthehelminthsecretomefortherapeuticimmunomodulators AT meissnerkamilaa harnessingthehelminthsecretomefortherapeuticimmunomodulators AT brattignorbert harnessingthehelminthsecretomefortherapeuticimmunomodulators AT wrengercarsten harnessingthehelminthsecretomefortherapeuticimmunomodulators AT liebaueva harnessingthehelminthsecretomefortherapeuticimmunomodulators |